semaglutide alopecia
Semaglutide Will Change Hair Loss Assessments By 2026
Semaglutide and tirzepatide have together generated over 5,000 reported alopecia cases in the FAERS database, signaling a need for vigilant monitoring in obesity treatment. These reports span 2014-2023 and highlight an emerging safety signal as the drugs gain wider use. Medical Disclaimer: This article is for informational purposes only